Poly(I:C)-induced tumour cell death leads to DC maturation and Th1 activation

Cancer Immunology, Immunotherapy

Volumn 60, Issue 11, 2011, Pages 1609-1624

  Kovalcsik, Edit ^a   Lowe, Katie ^a   Fischer, Mike ^a   Dalgleish, Angus ^a   Bodman Smith, Mark D ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Apoptosis; Dendritic cells; Poly(I:C); T helper cell type 1; Tumour cells

Indexed keywords

GAMMA INTERFERON; POLYINOSINIC POLYCYTIDYLIC ACID;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL ACTIVATION; CELL ACTIVITY; CELL FUNCTION; CELL MATURATION; CONTROLLED STUDY; DENDRITIC CELL; DRUG EFFICACY; DRUG MECHANISM; ENDOCYTOSIS; GAMMA IRRADIATION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TH1 CELL; TREATMENT RESPONSE; TUMOR CELL;

APOPTOSIS; CELL DEATH; CELL LINE, TUMOR; CYTOKINES; DENDRITIC CELLS; HUMANS; MAJOR HISTOCOMPATIBILITY COMPLEX; MELANOMA; POLY I-C; T-LYMPHOCYTES; TH1 CELLS;

EID: 82355185927     PISSN: 03407004     EISSN: 14320851     Source Type: Journal    
DOI: 10.1007/s00262-011-1058-7     Document Type: Article

References (82)

1. G Hacker 2000 The morphology of apoptosis Cell Tissue Res 301 5 17 10928277 10.1007/s004410000193 1:CAS:528:DC%2BD3cXlsFGnsro%3D (Pubitemid 30459851)
2. K Kurosaka M Takahashi N Watanabe Y Kobayashi 2003 Silent cleanup of very early apoptotic cells by macrophages J Immunol 171 4672 4679 14568942 1:CAS:528:DC%2BD3sXot1Cntrg%3D (Pubitemid 37310584)
3. J Savill I Dransfield C Gregory C Haslett 2002 A blast from the past: clearance of apoptotic cells regulates immune responses Nat Rev Immunol 2 965 975 12461569 10.1038/nri957 1:CAS:528:DC%2BD38XptFKnu7c%3D (Pubitemid 37323217)
4. G Pietra R Mortarini G Parmiani A Anichini 2001 Phases of apoptosis of melanoma cells, but not of normal melanocytes, differently affect maturation of myeloid dendritic cells Cancer Res 61 8218 8226 11719453 1:CAS:528: DC%2BD3MXovVShsLg%3D (Pubitemid 33091615)
5. VA Fadok DL Bratton A Konowal PW Freed JY Westcott PM Henson 1998 Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF J Clin Invest 101 890 898 9466984 10.1172/JCI1112 1:CAS:528:DyaK1cXht1Wrt70%3D (Pubitemid 28096086)
6. BL Jacobs JO Langland 1996 When two strands are better than one: the mediators and modulators of the cellular responses to double-stranded RNA Virology 219 339 349 8638399 10.1006/viro.1996.0259 1:CAS:528:DyaK28XjtVSgt74%3D (Pubitemid 126407667)
7. L Alexopoulou AC Holt R Medzhitov RA Flavell 2001 Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3 Nature 413 732 738 11607032 10.1038/35099560 1:CAS:528:DC%2BD3MXnvFegsL0%3D (Pubitemid 33009951)
8. H Kato O Takeuchi S Sato M Yoneyama M Yamamoto K Matsui S Uematsu A Jung T Kawai KJ Ishii O Yamaguchi K Otsu T Tsujimura CS Koh C Reis e Sousa Y Matsuura T Fujita S Akira 2006 Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses Nature 441 101 105 16625202 10.1038/nature04734 1:CAS:528:DC%2BD28XktVGltLk%3D
9. TR Meusel KE Kehoe F Imani 2002 Protein kinase R regulates double-stranded RNA induction of TNF-alpha but not IL-1 beta mRNA in human epithelial cells J Immunol 168 6429 6435 12055262 1:CAS:528:DC%2BD38XksFWmu74%3D (Pubitemid 34620067)
10. H Jonuleit U Kuhn G Muller K Steinbrink L Paragnik E Schmitt J Knop AH Enk 1997 Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions Eur J Immunol 27 3135 3142 9464798 10.1002/eji.1830271209 1:CAS:528: DyaK1cXisF2gug%3D%3D (Pubitemid 28018007)
11. J Banchereau RM Steinman 1998 Dendritic cells and the control of immunity Nature 392 245 252 9521319 10.1038/32588 1:CAS:528:DyaK1cXitFWrsr8%3D (Pubitemid 28155090)
12. F Sallusto M Cella C Danieli A Lanzavecchia 1995 Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products J Exp Med 182 389 400 7629501 10.1084/jem.182.2.389 1:CAS:528:DyaK2MXntFKhs70%3D
13. ML Albert SF Pearce LM Francisco B Sauter P Roy RL Silverstein N Bhardwaj 1998 Immature dendritic cells phagocytose apoptotic cells via alphavbeta5 and CD36, and cross-present antigens to cytotoxic T lymphocytes J Exp Med 188 1359 1368 9763615 10.1084/jem.188.7.1359 1:CAS:528:DyaK1cXmsFals78%3D (Pubitemid 28478024)
14. A Rubartelli A Poggi MR Zocchi 1997 The selective engulfment of apoptotic bodies by dendritic cells is mediated by the alpha(v)beta3 integrin and requires intracellular and extracellular calcium Eur J Immunol 27 1893 1900 9295024 10.1002/eji.1830270812 1:CAS:528:DyaK2sXltlCis70%3D (Pubitemid 27346003)
15. M Skoberne S Somersan W Almodovar T Truong K Petrova PM Henson N Bhardwaj 2006 The apoptotic-cell receptor CR3, but not alphavbeta5, is a regulator of human dendritic-cell immunostimulatory function Blood 108 947 955 16614246 10.1182/blood-2005-12-4812 1:CAS:528:DC%2BD28XnvFajtLg%3D (Pubitemid 44154630)
16. ML Albert B Sauter N Bhardwaj 1998 Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs Nature 392 86 89 9510252 10.1038/32183 1:CAS:528:DyaK1cXhvVOntrw%3D (Pubitemid 28150594)
17. J Banchereau F Briere C Caux J Davoust S Lebecque YJ Liu B Pulendran K Palucka 2000 Immunobiology of dendritic cells Annu Rev Immunol 18 767 811 10837075 10.1146/annurev.immunol.18.1.767 1:CAS:528:DC%2BD3cXjs1GmtrY%3D (Pubitemid 30365397)
18. EJ van Wilsem J Breve M Kleijmeer G Kraal 1994 Antigen-bearing Langerhans cells in skin draining lymph nodes: phenotype and kinetics of migration J Invest Dermatol 103 217 220 8040613 10.1111/1523-1747.ep12393088 (Pubitemid 24234611)
19. JM Blander 2007 Signalling and phagocytosis in the orchestration of host defence Cell Microbiol 9 290 299 17284172 10.1111/j.1462-5822.2006.00864.x 1:CAS:528:DC%2BD2sXhslGqsrk%3D (Pubitemid 46092159)
20. ML Kapsenberg CM Hilkens EA Wierenga P Kalinski 1999 The paradigm of type 1 and type 2 antigen-presenting cells. Implications for atopic allergy Clin Exp Allergy 29 Suppl 2 33 36 10421820 10.1046/j.1365-2222.1999.00006.x-i2 (Pubitemid 29314660)
21. A Taylor J Verhagen K Blaser M Akdis CA Akdis 2006 Mechanisms of immune suppression by interleukin-10 and transforming growth factor-beta: the role of T regulatory cells Immunology 117 433 442 16556256 10.1111/j.1365-2567.2006. 02321.x 1:CAS:528:DC%2BD28XjsVGks70%3D
22. MV Dhodapkar RM Steinman J Krasovsky C Munz N Bhardwaj 2001 Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells J Exp Med 193 233 238 11208863 10.1084/jem.193.2.233 1:CAS:528:DC%2BD3MXksl2ntQ%3D%3D (Pubitemid 32524454)
23. B Schuler-Thurner ES Schultz TG Berger G Weinlich S Ebner P Woerl A Bender B Feuerstein PO Fritsch N Romani G Schuler 2002 Rapid induction of tumor-specific type 1 T helper cells in metastatic melanoma patients by vaccination with mature, cryopreserved, peptide-loaded monocyte-derived dendritic cells J Exp Med 195 1279 1288 12021308 10.1084/jem.20012100 1:CAS:528:DC%2BD38XjvFegt7Y%3D (Pubitemid 34564330)
24. I Moller K Michel N Frech M Burger D Pfeifer P Frommolt H Veelken AK Thomas-Kaskel 2008 Dendritic cell maturation with poly(I:C)-based versus PGE2-based cytokine combinations results in differential functional characteristics relevant to clinical application J Immunother 31 506 519 18463533 10.1097/CJI.0b013e318177d9e5
25. RM Verdijk T Mutis B Esendam J Kamp CJ Melief A Brand E Goulmy 1999 Polyriboinosinic polyribocytidylic acid (poly(I:C)) induces stable maturation of functionally active human dendritic cells J Immunol 163 57 61 10384099 1:CAS:528:DyaK1MXktF2ruro%3D (Pubitemid 29295824)
26. F Sallusto A Lanzavecchia 1994 Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha J Exp Med 179 1109 1118 8145033 10.1084/jem.179.4.1109 1:CAS:528:DyaK2cXhs1Wjurg%3D
27. A Bender M Sapp G Schuler RM Steinman N Bhardwaj 1996 Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood J Immunol Methods 196 121 135 8841451 10.1016/0022-1759(96)00079-8 1:CAS:528:DyaK28XlsFWrtLs%3D (Pubitemid 26306734)
28. C Reis e Sousa SD Diebold AD Edwards N Rogers O Schulz R Sporri 2003 Regulation of dendritic cell function by microbial stimuli Pathol Biol (Paris) 51 67 68 10.1016/S0369-8114(03)00099-3 1:CAS:528:DC%2BD3sXktl2gsrg%3D (Pubitemid 36427573)
29. RB Mailliard A Wankowicz-Kalinska Q Cai A Wesa CM Hilkens ML Kapsenberg JM Kirkwood WJ Storkus P Kalinski 2004 Alpha-type-1 polarized dendritic cells: a novel immunization tool with optimized CTL-inducing activity Cancer Res 64 5934 5937 15342370 10.1158/0008-5472.CAN-04-1261 1:CAS:528:DC%2BD2cXntFClsro%3D (Pubitemid 39129387)
30. NP Restifo 2000 Building better vaccines: how apoptotic cell death can induce inflammation and activate innate and adaptive immunity Curr Opin Immunol 12 597 603 11007365 10.1016/S0952-7915(00)00148-5 1:CAS:528:DC%2BD3cXmsVKltLo%3D
31. M Obeid A Tesniere F Ghiringhelli GM Fimia L Apetoh JL Perfettini M Castedo G Mignot T Panaretakis N Casares D Metivier N Larochette P van Endert F Ciccosanti M Piacentini L Zitvogel G Kroemer 2007 Calreticulin exposure dictates the immunogenicity of cancer cell death Nat Med 13 54 61 17187072 10.1038/nm1523 1:CAS:528:DC%2BD2sXhvFWisw%3D%3D (Pubitemid 46067386)
32. R Medzhitov CA Janeway Jr 2000 How does the immune system distinguish self from nonself? Semin Immunol 12 185 188 10910738 10.1006/smim.2000.0230 1:CAS:528:DC%2BD3cXltVCit7k%3D (discussion 257-344) (Pubitemid 30479437)
33. E Ullrich M Bonmort G Mignot G Kroemer L Zitvogel 2008 Tumor stress, cell death and the ensuing immune response Cell Death Differ 15 21 28 17992190 10.1038/sj.cdd.4402266 1:CAS:528:DC%2BD2sXhsVegurzI (Pubitemid 350286169)
34. S Stevanovic 2002 Identification of tumour-associated T-cell epitopes for vaccine development Nat Rev Cancer 2 514 520 12094237 10.1038/nrc841 1:CAS:528:DC%2BD38XkvFKltLk%3D (Pubitemid 37336518)
35. J Banchereau AK Palucka 2005 Dendritic cells as therapeutic vaccines against cancer Nat Rev Immunol 5 296 306 15803149 10.1038/nri1592 1:CAS:528:DC%2BD2MXivVaku7c%3D (Pubitemid 40516155)
36. FO Nestle S Alijagic M Gilliet Y Sun S Grabbe R Dummer G Burg D Schadendorf 1998 Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells Nat Med 4 328 332 9500607 10.1038/nm0398-328 1:CAS:528:DyaK1cXhs1Kisrc%3D (Pubitemid 28144092)
37. BG Redman AE Chang J Whitfield P Esper G Jiang T Braun B Roessler JJ Mule 2008 Phase Ib trial assessing autologous, tumor-pulsed dendritic cells as a vaccine administered with or without IL-2 in patients with metastatic melanoma J Immunother 31 591 598 18528294 10.1097/CJI.0b013e31817fd90b 1:CAS:528:DC%2BD1cXnslKjt7o%3D
38. M Adams H Navabi B Jasani S Man A Fiander AS Evans C Donninger M Mason 2003 Dendritic cell (DC) based therapy for cervical cancer: use of DC pulsed with tumour lysate and matured with a novel synthetic clinically non-toxic double stranded RNA analogue poly [I]:poly [C(12)U] (Ampligen R) Vaccine 21 787 790 12531360 10.1016/S0264-410X(02)00599-6 1:CAS:528:DC%2BD3sXjtFKlsA%3D%3D (Pubitemid 36091998)
39. MG O'Rourke MK Johnson CM Lanagan JL See LE O'Connor GJ Slater D Thomas JA Lopez NR Martinez KA Ellem CW Schmidt 2007 Dendritic cell immunotherapy for stage IV melanoma Melanoma Res 17 316 322 17885587 10.1097/CMR.0b013e3282c3a73b (Pubitemid 47462224)
40. N Delirezh SM Moazzeni F Shokri MA Shokrgozar M Atri P Kokhaei 2009 Autologous dendritic cells loaded with apoptotic tumor cells induce T cell-mediated immune responses against breast cancer in vitro Cell Immunol 257 23 31 19306994 10.1016/j.cellimm.2009.02.002 1:CAS:528:DC%2BD1MXltVCrurk%3D
41. F Ghiringhelli PE Puig S Roux A Parcellier E Schmitt E Solary G Kroemer F Martin B Chauffert L Zitvogel 2005 Tumor cells convert immature myeloid dendritic cells into TGF-beta-secreting cells inducing CD4+ CD25+ regulatory T cell proliferation J Exp Med 202 919 929 16186184 10.1084/jem.20050463 1:CAS:528:DC%2BD2MXhtVygt73F (Pubitemid 41396892)
42. V Russo S Tanzarella P Dalerba D Rigatti P Rovere A Villa C Bordignon C Traversari 2000 Dendritic cells acquire the MAGE-3 human tumor antigen from apoptotic cells and induce a class I-restricted T cell response Proc Natl Acad Sci USA 97 2185 2190 10681453 10.1073/pnas.040540197 1:CAS:528: DC%2BD3cXhslKht7w%3D (Pubitemid 30134043)
43. RS Goldszmid J Idoyaga AI Bravo R Steinman J Mordoh R Wainstok 2003 Dendritic cells charged with apoptotic tumor cells induce long-lived protective CD4+ and CD8+ T cell immunity against B16 melanoma J Immunol 171 5940 5947 14634105 1:CAS:528:DC%2BD3sXptFOks7Y%3D (Pubitemid 37467212)
44. E Kovalcsik J John M Turner L Birchall D Sage R Whittle A Dalgleish H Pandha 2004 Differential expression of melanoma-associated antigens and molecules involved in antigen processing and presentation in three cell lines established from a single patient Melanoma Res 14 463 471 15577316 10.1097/00008390-200412000-00005 1:CAS:528:DC%2BD2cXhtVertb7F (Pubitemid 40221136)
45. N Romani D Reider M Heuer S Ebner E Kampgen B Eibl D Niederwieser G Schuler 1996 Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability J Immunol Methods 196 137 151 8841452 10.1016/0022-1759(96)00078-6 1:CAS:528:DyaK28XlsFWrtLg%3D (Pubitemid 26306735)
46. P Kalinski E Wieckowski R Muthuswamy E de Jong 2010 Generation of stable Th1/CTL-, Th2-, and Th17-inducing human dendritic cells Methods Mol Biol 595 117 133 19941108 10.1007/978-1-60761-421-0-7 1:CAS:528:DC%2BC3cXos1Cqu7w%3D
47. P Lane C Burdet F McConnell A Lanzavecchia E Padovan 1995 CD40 ligand-independent B cell activation revealed by CD40 ligand-deficient T cell clones: evidence for distinct activation requirements for antibody formation and B cell proliferation Eur J Immunol 25 1788 1793 7615009 10.1002/eji.1830250646 1:CAS:528:DyaK2MXms1KlsLk%3D
48. AD Garg D Nowis J Golab P Vandenabeele DV Krysko P Agostinis 2009 Immunogenic cell death, DAMPs and anticancer therapeutics: an emerging amalgamation Biochim Biophys Acta 1805 53 71 19720113
49. M Obeid T Panaretakis N Joza R Tufi A Tesniere P van Endert L Zitvogel G Kroemer 2007 Calreticulin exposure is required for the immunogenicity of gamma-irradiation and UVC light-induced apoptosis Cell Death Differ 14 1848 1850 17657249 10.1038/sj.cdd.4402201 1:CAS:528:DC%2BD2sXhtVCisbrO (Pubitemid 47423653)
50. E Wieckowski GS Chatta RM Mailliard W Gooding K Palucka J Banchereau P Kalinski 2010 Type-1 polarized dendritic cells loaded with apoptotic prostate cancer cells are potent inducers of CD8(+) T cells against prostate cancer cells and defined prostate cancer-specific epitopes Prostate 71 125 133 20717900 10.1002/pros.21228
51. J Denoeud M Moser 2010 Role of CD27/CD70 pathway of activation in immunity and tolerance J Leukoc Biol 89 195 203 20699361 10.1189/jlb.0610351
52. A Tamir E Basagila A Kagahzian L Jiao S Jensen J Nicholls P Tate G Stamp F Farzaneh P Harrison H Stauss AJ George N Habib RI Lechler G Lombardi 2007 Induction of tumor-specific T-cell responses by vaccination with tumor lysate-loaded dendritic cells in colorectal cancer patients with carcinoembryonic-antigen positive tumors Cancer Immunol Immunother 56 2003 2016 17333181 10.1007/s00262-007-0299-y (Pubitemid 47512607)
53. P Hatfield AE Merrick E West D O'Donnell P Selby R Vile AA Melcher 2008 Optimization of dendritic cell loading with tumor cell lysates for cancer immunotherapy J Immunother 31 620 632 18600182 10.1097/CJI.0b013e31818213df
54. PL Vieira EC de Jong EA Wierenga ML Kapsenberg P Kalinski 2000 Development of Th1-inducing capacity in myeloid dendritic cells requires environmental instruction J Immunol 164 4507 4512 10779751 1:CAS:528: DC%2BD3cXivFWmt74%3D (Pubitemid 30238046)
55. N Cools P Ponsaerts VF Van Tendeloo ZN Berneman 2007 Balancing between immunity and tolerance: an interplay between dendritic cells, regulatory T cells, and effector T cells J Leukoc Biol 82 1365 1374 17711977 10.1189/jlb.0307166 1:CAS:528:DC%2BD2sXhsValtbfM (Pubitemid 350276946)
56. P Kalinski CM Hilkens EA Wierenga ML Kapsenberg 1999 T-cell priming by type-1 and type-2 polarized dendritic cells: the concept of a third signal Immunol Today 20 561 567 10562707 10.1016/S0167-5699(99)01547-9 1:CAS:528:DyaK1MXns1Sgurk%3D
57. R Trepiakas AE Pedersen O Met MH Hansen A Berntsen IM Svane 2008 Comparison of alpha-Type-1 polarizing and standard dendritic cell cytokine cocktail for maturation of therapeutic monocyte-derived dendritic cell preparations from cancer patients Vaccine 26 2824 2832 18450338 10.1016/j.vaccine.2008.03.054 1:CAS:528:DC%2BD1cXmtVSgu7w%3D
58. AS Giermasz JA Urban Y Nakamura P Watchmaker RL Cumberland W Gooding P Kalinski 2009 Type-1 polarized dendritic cells primed for high IL-12 production show enhanced activity as cancer vaccines Cancer Immunol Immunother 58 1329 1336 19156413 10.1007/s00262-008-0648-5 1:CAS:528:DC%2BD1MXmsVGju7o%3D
59. B Salaun I Coste MC Rissoan SJ Lebecque T Renno 2006 TLR3 can directly trigger apoptosis in human cancer cells J Immunol 176 4894 4901 16585585 1:CAS:528:DC%2BD28XjtV2gtr0%3D
60. B Salaun S Lebecque S Matikainen D Rimoldi P Romero 2007 Toll-like receptor 3 expressed by melanoma cells as a target for therapy? Clin Cancer Res 13 4565 4574 17671143 10.1158/1078-0432.CCR-07-0274 1:CAS:528: DC%2BD2sXotlGqu7g%3D (Pubitemid 47219727)
61. S Balachandran PC Roberts T Kipperman KN Bhalla RW Compans DR Archer GN Barber 2000 Alpha/beta interferons potentiate virus-induced apoptosis through activation of the FADD/Caspase-8 death signaling pathway J Virol 74 1513 1523 10627563 10.1128/JVI.74.3.1513-1523.2000 1:CAS:528:DC%2BD3cXmtFynuw%3D%3D (Pubitemid 30044102)
62. J Tissari J Siren S Meri I Julkunen S Matikainen 2005 IFN-alpha enhances TLR3-mediated antiviral cytokine expression in human endothelial and epithelial cells by up-regulating TLR3 expression J Immunol 174 4289 4294 15778392 1:CAS:528:DC%2BD2MXisVChtrk%3D (Pubitemid 40396010)
63. A Sato M Iizuka O Nakagomi M Suzuki Y Horie S Konno F Hirasawa K Sasaki K Shindo S Watanabe 2006 Rotavirus double-stranded RNA induces apoptosis and diminishes wound repair in rat intestinal epithelial cells J Gastroenterol Hepatol 21 521 530 16638093 10.1111/j.1440-1746.2005.03977.x 1:CAS:528:DC%2BD28XltFaiu7s%3D
64. R Besch H Poeck T Hohenauer D Senft G Hacker C Berking V Hornung S Endres T Ruzicka S Rothenfusser G Hartmann 2009 Proapoptotic signaling induced by RIG-I and MDA-5 results in type I interferon-independent apoptosis in human melanoma cells J Clin Invest 119 2399 2411 19620789 1:CAS:528: DC%2BD1MXpsFCksr0%3D
65. EL Smits P Ponsaerts AL Van de Velde A Van Driessche N Cools M Lenjou G Nijs DR Van Bockstaele ZN Berneman VF Van Tendeloo 2007 Proinflammatory response of human leukemic cells to dsRNA transfection linked to activation of dendritic cells Leukemia 21 1691 1699 17525722 10.1038/sj.leu.2404763 1:CAS:528:DC%2BD2sXnvVelur8%3D (Pubitemid 47086759)
66. AN Cornforth AW Fowler DJ Carbonell RO Dillman 2011 Resistance to the proapoptotic effects of interferon-gamma on melanoma cells used in patient-specific dendritic cell immunotherapy is associated with improved overall survival Cancer Immunol Immunother 60 123 131 20960187 10.1007/s00262-010-0925-y 1:CAS:528:DC%2BC3MXht12gtrg%3D
67. T Chen J Guo M Yang X Zhu X Cao 2011 Chemokine-containing exosomes are released from heat-stressed tumor cells via lipid raft-dependent pathway and act as efficient tumor vaccine J Immunol 186 2219 2228 21242526 10.4049/jimmunol.1002991 1:CAS:528:DC%2BC3MXhsVSgsL4%3D
68. S Knudsen A Schardt T Buhl L Boeckmann MP Schon C Neumann HA Haenssle 2010 Enhanced T-cell activation by immature dendritic cells loaded with HSP70-expressing heat-killed melanoma cells Exp Dermatol 19 108 116 19758341 10.1111/j.1600-0625.2009.00962.x 1:CAS:528:DC%2BC3cXjtVymtL8%3D
69. S Yokota N Fujii 2010 Immunomodulatory activity of extracellular heat shock proteins and their autoantibodies Microbiol Immunol 54 299 307 20536727 1:CAS:528:DC%2BC3cXmvFajtr8%3D
70. G Uze D Monneron 2007 IL-28 and IL-29: newcomers to the interferon family Biochimie 89 729 734 17367910 10.1016/j.biochi.2007.01.008 1:CAS:528: DC%2BD2sXnsFKrtb8%3D (Pubitemid 47001631)
71. JM Blander R Medzhitov 2006 Toll-dependent selection of microbial antigens for presentation by dendritic cells Nature 440 808 812 16489357 10.1038/nature04596 1:CAS:528:DC%2BD28XjtFKjsLo%3D
72. O Schulz SS Diebold M Chen TI Naslund MA Nolte L Alexopoulou YT Azuma RA Flavell P Liljestrom C Reis e Sousa 2005 Toll-like receptor 3 promotes cross-priming to virus-infected cells Nature 433 887 892 15711573 10.1038/nature03326 1:CAS:528:DC%2BD2MXhsFOrtbg%3D (Pubitemid 40314900)
73. L Kacani M Wurm I Schwentner J Andrle H Schennach GM Sprinzl 2005 Maturation of dendritic cells in the presence of living, apoptotic and necrotic tumour cells derived from squamous cell carcinoma of head and neck Oral Oncol 41 17 24 15598581 10.1016/j.oraloncology.2004.05.006 (Pubitemid 39647115)
74. T Felzmann KG Huttner SK Breuer D Wimmer G Ressmann D Wagner P Paul M Lehner A Heitger W Holter 2005 Semi-mature IL-12 secreting dendritic cells present exogenous antigen to trigger cytolytic immune responses Cancer Immunol Immunother 54 769 780 15647926 10.1007/s00262-004-0637-2 1:CAS:528: DC%2BD2MXmtVajtrY%3D (Pubitemid 40977145)
75. JS Frick F Grunebach IB Autenrieth 2010 Immunomodulation by semi-mature dendritic cells: a novel role of Toll-like receptors and interleukin-6 Int J Med Microbiol 300 19 24 19781988 10.1016/j.ijmm.2009.08.010 1:CAS:528: DC%2BC3cXjt1ajs7Y%3D
76. G Schuler B Schuler-Thurner RM Steinman 2003 The use of dendritic cells in cancer immunotherapy Curr Opin Immunol 15 138 147 12633662 10.1016/S0952-7915(03)00015-3 1:CAS:528:DC%2BD3sXhvFaiu7w%3D (Pubitemid 36287518)
77. MP Longhi C Trumpfheller J Idoyaga M Caskey I Matos C Kluger AM Salazar M Colonna RM Steinman 2009 Dendritic cells require a systemic type I interferon response to mature and induce CD4+ Th1 immunity with poly IC as adjuvant J Exp Med 206 1589 1602 19564349 10.1084/jem.20090247 1:CAS:528:DC%2BD1MXos1eisLc%3D
78. K Abdi N Singh P Matzinger 2006 T-cell control of IL-12p75 production Scand J Immunol 64 83 92 16867152 10.1111/j.1365-3083.2006.01767.x 1:CAS:528:DC%2BD28XptFWksb0%3D (Pubitemid 44034311)
79. G Napolitani A Rinaldi F Bertoni F Sallusto A Lanzavecchia 2005 Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1-polarizing program in dendritic cells Nat Immunol 6 769 776 15995707 10.1038/ni1223 1:CAS:528:DC%2BD2MXmtlSisLs%3D (Pubitemid 43090462)
80. RM Steinman 2003 Some interfaces of dendritic cell biology Apmis 111 675 697 12974772 10.1034/j.1600-0463.2003.11107802.x 1:CAS:528:DC%2BD3sXotFyqtbk%3D (Pubitemid 37130017)
81. SS Jensen M Gad 2010 Differential induction of inflammatory cytokines by dendritic cells treated with novel TLR-agonist and cytokine based cocktails: targeting dendritic cells in autoimmunity J Inflamm (Lond) 7 37 10.1186/1476-9255-7-37
82. I Tirapu A Lewis M Kreutz H McLinden SS Diebold 2008 Freeze-and-thaw- disrupted tumour cells impair the responsiveness of DC to TLR stimulation Eur J Immunol 38 2740 2750 18825742 10.1002/eji.200838284 1:CAS:528:DC%2BD1cXhtlOjs7fL